Both in Biotechnology
eXoZymes vs INmune Bio
Over the past year EXOZ returned −57.9% and INMB returned −7.1%; their daily moves had a correlation of 0.15.
EXOZ −57.9% INMB −7.1%Growth of $1, one year, split-adjusted
| Metric | EXOZ | INMB |
|---|---|---|
| Price | $6.10 | $1.96 |
| Market cap | $56.6M | $54.4M |
| Today | +1.67% | −2.00% |
| 1 month | −14.9% | −15.9% |
| 6 months | −16.4% | +71.9% |
| Year to date | −44.0% | +25.6% |
| 1 year | — | −2.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $5.6M | $18.4M |
| Dividend yield | — | — |
| Volatility (60d) | 82.0% | 71.9% |
| Short % of float | 0.7% | 9.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).